Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials
Background: Six biologic agents are now approved for patients with severe asthma. This meta-analysis aimed to assess the efficacy and safety of licensed biologic agents in patients with severe asthma, including the recently approved tezepelumab. Methods: We searched MEDLINE, Embase and CENTRAL to id...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2024-04-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/33/172/230238.full |